Please complete the CAPTCHA to continue
@amgen.com
✓
2 phones found area 914
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
K. Danielle Urry, Md, Mph is listed as Senior Medical Science Liaison @ LivaNova | MD, MPH at LivaNova, based in Monterey, California, United States. AeroLeads shows a work email signal at amgen.com, phone signal with area code 914, and a matched LinkedIn profile for K. Danielle Urry, Md, Mph.
K. Danielle Urry, Md, Mph previously worked as Senior Medical Science Liaison at Livanova and Sr. Medical Science Liaison at Amgen. K. Danielle Urry, Md, Mph holds Md, Medicine from Poznan University Of Medical Sciences.
This section adds company-level context without repeating K. Danielle Urry, Md, Mph's masked contact details.
AeroLeads found 1 current-domain work email signal for K. Danielle Urry, Md, Mph. Compare company email patterns before reaching out.
As a Senior Medical Science Liaison at LivaNova, I support several critical functions internally and externally, such as medical reviewer and presenter at major annual congresses of primary strategic data. I have over 10 years of experience in medical affairs, spanning across medical device and pharma, and multiple therapeutic areas, including epilepsy, cardiology, and rheumatology.I am passionate about improving clinical care and knowledge by building collaborative relationships with key opinion leaders, conducting and disseminating clinical research, and contributing to product development and innovation. I hold an MD from Akademia Medyczna in Poznan, Poland, and an MPH from Columbia University, with a specialization in biostatistics and sociomedical sciences. I also have multiple certifications and publications in lipidology, drug development, and genomics. I am fluent in Spanish, Polish, and French.
Listed skills include Clinical Research, Public Health, Biotechnology, Medicine, and 31 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
London, Gb
Support several critical functions internally and externally- e.g., medical reviewer and presenter at major annual congress of primary strategic data. Publishing in key journals around key company topics.
Thousand Oaks, Ca, Us
Clinical Trial Lead for Field Medical for "AMG 890." This is the first Cardiovascular gene therapy product Amgen has. It is out-licensed by Amgen- and is an RNAi targeted against lp(a). It is currently entering phase 2 trials. Field Medical's Heart Failure Compound Lead for the Western Half of the United States. This is Amgen's phase 3 HF compound. Clinical Trial Lead for the West: producing a newsletter for the approx. 45 RMLs in the US on all approx 14 trials from phase 2- phase 4 Real World Evidence/post-market trials. Co-creation of an efficient "Hub" for Field Medical to access intensive activities in clinical trial support.Advance Amgen's Scientific Image within the Lipid and Heart Failure arena as relevant to General Cardiologists, Endocrinologists, Interventional Cardiologists, and Heart Failure Specialists.Invited by Executive Leadership to attend internal AdBoards as a Field Medical representative and apply for roles of advancement within Medical and laterally in Clinical Development.
Dublin, Ireland, Ie
Contribute to the ongoing collaborations with academic centers: UCSF, Stanford (attend weekly grand rounds), UCDavis, Berkeley in the area of investigator initiated studies, research fellowships, and publications within Rheumatology.Nominated into the American College of Rheumatology where I serve to stay abreast of current clinical trials and treatment algorithms within Rheumatology in the areas of rheumatoid arthritis, lupus, ankylosing spondylitis, myositis, vasculitis, and sarcoidosis. Lead the weekly team calls for Rheumatology Medical AffairsAssist physicians by accurately and precisely discussing academic data in peer-reviewed journals in the field of Rheumatology and Rare Diseases.
Forchheim, De
Advance Siemens scientific image through congress presentations, webinars, KOL relationships, etc with objective and balanced medical and scientific information: including current practice guidelines, and a broad array of areas of research.Contributed to multifunctional teams through R&D to weigh in on CSRs in the cardiovascular space.Develop and give presentations for major stakeholders, worth several million: e.g., Kaiser Permanente, Med Assets, CHS, on the research and clinical excellence of our products in: cardiology, oncology, infectious disease, endocrinology, and the disease state areas of responsibility continue to expand.Ensure that the clinical and scientific team's role is consistent with legal and regulatory practice.Identify and communicate business and scientific market trends in the US healthcare environmentServe as a resource for education and dissemination of pertinent, clear, and balanced medical-scientific information to internal and external audiencesWork with multidisciplinary teams to develop and prepare presentations. Work with clinical scientific writers, create scientific/clinical publications and deliver to relevant audiences at medical and clinical conferences.
Therapeutic areas: neuroscience, oncology, drug targetingResearched relevant drug transporter in Oncology and blood brain barrier metabolismCo-authored relevant publications from research findingsTranslated findings into medical applicationsPresented clinical and scientific data to academic audiences as well as potential investors to secure funding for ongoing research and clinical development of new technology for drug targeting and drug delivery.• Co-inventor of pending patent that works on drug optimization, targeting, delivery for chemotherapeutics, and drug metabolism. (Patent application number 20100330606) • Conduct analysis of the pharmaceutical pipeline and clinical developments within oncology regarding drug targeting and general drug delivery mechanisms, particularly within the area of novel polymer therapeutics.
Develop strategic relationships with key decision makers in pharmaceutical, biotechnology, and medical device companies to promote participation and attendance at international symposiums. Spearhead fundraising activities with major banks to secure funding for the research and development of new projects. • Leverage relationships to introduce key contacts to relevant global development projects and funding sources.• Successfully established a scientific collaboration with Columbia University for academic programs that interface with WEF in their international affairs department.• Build cross-functional collaborative relationships with Key Opinion Leaders (KOLs) in academia and pharmaceuticals, and with executives in the banking industry to achieve project goals.
New York, Ny, Us
Conducted and coordinated 3 meta-analytic and 1 theoretical reviews related to the impact of chronic stress on cardiovascular outcomes as well as all-cause mortality. Trained in ICH and GCP with working knowledge of clinical trial regulations. • Participated in the beginning of a clinical trial for an antihypertensive drug
New York, Ny, Us
Managed NIH funded pilot study: coordinated, designed and conducted qualitative surveys examining knowledge, attitudes, and beliefs related to decision making regarding sexual behavior among young adults living in New York City.• Worked in the laboratory of Vimla Patel, Ph.D., D.Sc. • Contributed to grant submission for international HIV/AIDS research. CDC Knight Fellowship for Journalism in Science • Recipient of 2006 CDC fellowship award from the Knight Foundation for excellence in public health communication and epidemiology.
Conducted transformations and cloning of a transport protein that is central to the reproduction of T. gondii within the host to better understand how a drug can target T. gondii, a parasite that infects over 10 million persons worldwide. Co-authored relevant poster publication for Woods Hole Conference in August 2003.
Conducted prospective clinical research (app 300 subjects) using Microsoft Access and Microsoft Excel into the various factors associated with the clinical disorder, 22q11.2, a rare chromosomal abnormality that is the specialty of the Pediatric Clinical Genetics Department.
Quick answers generated from the profile data available on this page.
K. Danielle Urry, Md, Mph works for LivaNova.
K. Danielle Urry, Md, Mph is listed as Senior Medical Science Liaison @ LivaNova | MD, MPH at LivaNova.
AeroLeads has found 1 work email signal at @amgen.com for K. Danielle Urry, Md, Mph at LivaNova.
AeroLeads has found 2 phone signal(s) with area code 914 for K. Danielle Urry, Md, Mph at LivaNova.
K. Danielle Urry, Md, Mph is based in Monterey, California, United States while working with LivaNova.
K. Danielle Urry, Md, Mph has worked for Livanova, Amgen, Mallinckrodt Pharmaceuticals, Siemens Healthcare, and Bioelastics Inc.,Llc , Bioelastics Research Limited (Uip).
You can use AeroLeads to view verified contact signals for K. Danielle Urry, Md, Mph at LivaNova, including work email, phone, and LinkedIn data when available.
K. Danielle Urry, Md, Mph holds Md, Medicine from Poznan University Of Medical Sciences.
K. Danielle Urry, Md, Mph is listed with skills including Clinical Research, Public Health, Biotechnology, Medicine, Oncology, Healthcare, Pharmaceutical Industry, and Medical Devices.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts